NIH Awards BU Clinical & Translational Science Institute $41 Million in New Funding
Seven-year grant will support programs that aim to pioneer lifesaving healthcare innovations and spur team science and multidisciplinary collaborations.
Video: Leaders Among Us—President Gilliam in Conversation with Yvette Cozier
School of Public Health researcher talks about BU’s Black Women’s Health Study.
Prominent Women’s Health Researcher and Academic Leader Named Dean of BU Chobanian & Avedisian School of Medicine
Geeta Swamy joins Boston University from Duke University.
BU-Led Framingham Heart Study Brain Aging Program Receives $31.5 Million Funding Renewal
National Institute on Aging’s five-year grant will help researchers advance understanding of Alzheimer’s and related dementias.
Chobanian & Avedisian School of Medicine’s Chief Resident Immersion Training (CRIT) Marks 25th anniversary
Program helps new chief residents diagnose, treat, and teach about addiction.
US Sunscreens Just Got More Effective. BU Dermatologist Explains Why
Michael Kwa calls approval of new ingredient, bemotrizinol, exciting for safety.
Boston University-Based Biopharmaceutical Accelerator Boosts New Drugs’ Chances of Success, Study Finds
CARB-X-backed novel therapeutics to combat antimicrobial resistance are nearly five times more likely to reach clinical development.
How Worried Should We Be About the Bundibugyo Ebola Outbreak?
Boston University researchers are helping track disease’s spread and preparing to test new treatments.
Measles, Cholera, and Mpox: BU-Based Outbreak Tracker Monitors World’s Most Dangerous Infectious Diseases
In its first year, BEACON has helped direct public health responses globally, monitoring 181 pathogens in 169 countries—and 1 in space.
Two Boston University Researchers Elected AAAS Fellows
Prestigious honor given to neuroscientist who studies diseases of aging and physicist whose work spans medicine to AI.